Psychology & Intimacy The Anti-Aging Drug Combination Dasatinib+Quercetin Linked to Significant Brain Damage in Mice June 4, 2026 Rebecca Shoemaker A promising drug combination widely lauded for its anti-aging potential, dasatinib and quercetin (D+Q), has revealed a concerning side effect: significant brain damage in mice. Researchers at the University of…
Sexual Health & Medical Wellness Zoliflodacin Emerges as Promising Single-Dose Oral Treatment for Drug-Resistant Gonorrhea Following Successful Phase 3 Clinical Trials May 28, 2026 Susilo Ahmad Researchers are poised to revolutionize the treatment landscape for gonorrhea with the successful completion of a late-stage phase 3 clinical trial for a novel oral medication, zoliflodacin. Published in the…
Psychology & Intimacy The Anti-Aging Drug Combination Dasatinib-Quercetin Shows Serious Brain Damage Potential in Mice May 27, 2026 Rebecca Shoemaker A groundbreaking study from the University of Connecticut has cast a stark shadow over the burgeoning field of anti-aging research, revealing that a widely investigated drug combination, dasatinib and quercetin…
Sexual Health & Medical Wellness New antibiotic pill shows promise against drug-resistant gonorrhea May 20, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler and more effective way to treat gonorrhea, particularly strains that have developed resistance to existing antibiotics,…
Sexual Health & Medical Wellness Breakthrough Oral Medication Zoliflodacin Nears Approval, Offering New Hope in the Global Fight Against Drug-Resistant Gonorrhea May 13, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler way to treat gonorrhea, especially strains that no longer respond well to existing antibiotics. In a…
Sexual Health & Medical Wellness New antibiotic pill shows promise against drug-resistant gonorrhea May 6, 2026 Susilo Ahmad A significant breakthrough in the global fight against sexually transmitted infections (STIs) is on the horizon, as researchers announce promising results for zoliflodacin, a novel oral medication designed to treat…
Psychology & Intimacy The Brain Unlocked: Decades-Old Diabetes Drug Metformin’s Secret Mechanism Revealed May 1, 2026 Rebecca Shoemaker For over six decades, metformin has stood as a cornerstone of type 2 diabetes management, a ubiquitous prescription lauded for its efficacy in lowering blood glucose levels. Yet, despite its…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Promising Oral Solution in the Global Battle Against Drug-Resistant Gonorrhea April 28, 2026 Susilo Ahmad Researchers are heralding a significant advancement in the fight against gonorrhea, a pervasive sexually transmitted infection, with the development of a novel oral medication named zoliflodacin. This investigational drug holds…
Sexual Health & Medical Wellness Zoliflodacin Offers New Hope in the Global Fight Against Drug-Resistant Gonorrhea with Promising Phase 3 Trial Results. April 21, 2026 Susilo Ahmad A significant breakthrough in the treatment of gonorrhea, one of the world’s most prevalent and increasingly drug-resistant sexually transmitted infections (STIs), has emerged with the successful conclusion of a late-stage…
Sexual Health & Medical Wellness New antibiotic pill shows promise against drug-resistant gonorrhea April 14, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler, yet highly effective, way to treat gonorrhea, especially strains that no longer respond well to existing…
